News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
Hripsime-Gina Martirosyan: Advocating for cancer care in Armenia: how it works in a resource-limited country
Photo from Hripsime-Gina Martirosyan/LinkedIn
04/11/2023 00:33

Hripsime-Gina Martirosyan: Advocating for cancer care in Armenia: how it works in a resource-limited country

“Thrilled to be an invited speaker at the ESMO2023 Patient Advocacy Track in Madrid, Spain, and speak about ‘Advocating for cancer care in Armenia: how it works in a resource-limited country’.

HENARAN charitable foundation‘s 7 years of tireless work brought us to the state of speaking at a key European forum and now inspires to work even harder and achieve new horizons.”

Quoting

“On October 20-24, the annual congress of ESMO (European Society of Medical Oncology) took place in Madrid, Spain, where by one of the most important components is the Patient Advocacy Track. After becoming an ESMO member in 2018, “HENARAN” foundation is a regular participant of ESMO annual congresses. This year “HENARAN” foundation not only participated, but also was invited to ESMO2023 congress as a speaker to present on cancer advocacy in Armenia and programs implemented by “HENARAN”.

Hripsime Martirosyan, the Founding Director of “HENARAN”, in her speech referred to the current situation of cancer care in Armenia and various programs implemented since “HENARAN” foundation’s inception in February 2017. She dwelled in more detail on two major programs where “HENARAN” has played a significant role.

The first is the breast cancer screening pilot project, for implementation of which “HENARAN” developed professional guidelines and protocols, as well as a training manual for primary healthcare physicians to realize screening of women, which were put into practice in January 2021 and so far have been successfully applied in Lori, Tavush, and Syunik, and recently also in Shirak.

And the second project is creating the electronic cancer registry of Armenia, to replace the old paper-based registry, which incorporated international TNM, ICD-10, ICD-O classifications that are very important to capture cancer data.

We are delighted to present Hripsime’s talk in English for a multinational audience of this international platform, please follow the video’s link in Facebook here.”

For more details click here.
Source:

cancer ESMO23 HENARAN charitable foundation Hripsime-Gina Martirosyan OncoDaily Oncology Patient Advocacy Track
Blog
16:27 30/11/23
David Lubarsky: 4 Ms
Drugs
16:23 30/11/23
Mariana Brandao: My comment on the ARTEMIDE-01 phase I trial testing a new bispecific anti-PD-1/anti-TIGIT antibody called Rilvegostomig
Blog
16:18 30/11/23
Do you want to be part of the first-ever national cancer innovation accelerator initiative with public support from The White House? - CancerX Moonshot
Opinion
16:11 30/11/23
Gavin Preston: If thinking of going into medicine to get rich, forget it
Blog
16:04 30/11/23
Two charities will co-fund a major £5.5 million research programme called Stratified Medicine Paediatrics 2 - The Institute of Cancer Research
Blog
15:58 30/11/23
Aju Mathew: Rising numbers of hepatocellular carcinoma in India
Blog
15:51 30/11/23
Bente Mikkelsen: This is the latest edition of the IARC handbook series and covers the topic of oral cancer prevention
Blog
15:43 30/11/23
Rebekka K. Schneider: Our research will be supported by an European Research Council (ERC) consolidator grant
Blog
15:39 30/11/23
Otilia Ciobanu: Review on the potential of targeting the subventricular zone for improved outcomes in high-grade gliomas
Blog
15:33 30/11/23
Andre Lopes Carvalho: I had the incredible opportunity to celebrate the 20th anniversary of ZORA
Drugs
15:29 30/11/23
David Steensma: Randomized STIMULUS-MDS1 trial didn't meet endpoint
Blog
15:25 30/11/23
Monica M. Bertagnolli: One of my priorities is ensuring all people are represented in clinical trials
Insight
Positive
Societies
Career